ProCE Banner Activity

Targeting DNA Repair Defects in Prostate Cancer: The Role of PARP Inhibitors

Slideset Download
Download this slideset to get up to date on the latest clinical evidence for PARP inhibition in the care of patients with advanced prostate cancer.

Released: February 14, 2019

Expiration: February 13, 2020

No longer available for credit.

Share

Faculty

Charles Ryan

Charles Ryan, MD

Associate Clinical Professor
Department of Medicine Hematology/Oncology
University of California, San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Clovis Oncology

Pfizer, Inc.

Faculty Disclosure

Primary Author

Charles Ryan, MD

Associate Clinical Professor
Department of Medicine Hematology/Oncology
University of California, San Francisco
San Francisco, California